ATHX
Athersys, Inc.
A biotechnology company that grows special stem cells, called MultiStem, from the bone marrow of healthy adult donors to make an "off-the-shelf" therapy for critical-care conditions like stroke, heart attack, and lung injury. Founded in 1995 in Cleveland, it first tried to build a synthetic human chromosome for gene therapy before switching to regenerative medicine. Its cells act as a temporary "living drug" that calms inflammation and helps the body heal, then clears out on their own.
CUSIP: 04744L106HealthcareUS1 holder1 derivative reporter
Total Value
$2.33M
Total Shares
807.6K
Net Share Change
+95.1K
Activity
1 buying
Investor
Value
Shares
Weight
Change
